1
Zhiping Jiang, Raymond P Fisk, John E O Gara, Thomas H Walter, Kevin D Wyndham: Porous inorganic/organic hybrid particles for chromatographic separations and process for their preparation. Waters Technologies Corporation, Edwards Angell Palmer & Dodge, Peter C Lauro Esq, Mark D Russett Esq, April 5, 2011: US07919177 (8 worldwide citation)

Novel material for chromatographic separations, processes for its preparation, and separations devices containing the chromatographic material. In particular, the disclosure describes porous inorganic/organic hybrid particles having a chromatographically-enhancing pore geometry, which desirably may ...


2
Thomas E Wheat, Charles H Phoebe, Mark K Baynham, Uwe Dieter Neue, Raymond P Fisk, Richard C Turner: Mobile phase dilution scheme for enhanced chromatography. Waters Technologies Corporation, Edwards Angell Palmer & Dodge, Peter C Lauro Esq, Mark D Russett Esq, January 25, 2011: US07875175 (2 worldwide citation)

A method and device for increasing the loading capacity of a chromatography column through dilution of a mobile phase at the head of the column. A strong mobile phase is provided for dissolving a sample. A sample is injected into the strong mobile phase, and subsequently diluted with a weak mobile p ...


3
Tatsuya Masuki, Tahara Hisashi: Resin container. Mitsubishi Engineering Plastics Corporation, Edwards Angell Palmer & Dodge, David G Conlin Esq, Mark D Russett Esq, February 12, 2008: US07329443 (1 worldwide citation)

A resin container is provided which has a container body and a lid for closing the container body. The container body of the resin container is produced by injection-molding an amorphous thermoplastic resin. The container body form has a peripheral rise portion and a recessed flat portion defined by ...


4
Peter Jeng Jong Lee, John E O Gara: Ion exchange porous resins for solid phase extraction and chromatography. Waters Technologies Corporation, Edwards Angell Palmer & Dodge, Peter C Lauro Esq, Mark D Russett Esq, September 7, 2010: US07790038

Embodiments of the present invention are directed to porous resins for solid phase extractions. The resins feature at least one hydrophobic component, at least one hydrophilic component and at least one ion exchange functional group. The resins exhibit superior wetting and ion exchange performance.


5
David R Elmaleh, Alan J Fischman, Timothy M Shoup: Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid. The General Hospital Corporation, Edwards Wildman Palmer, Peter C Lauro Esq, Mark D Russett Esq, November 13, 2012: US08309053

The present invention relates to novel modified fatty acid analogs, where a positron or gamma-emitting label is placed at a position on a fatty acid backbone and an organic substituent is substituted at the 2,3; 3,4; 4,5; 5,6 and other sequence positions of a fatty acid backbone. These novel fatty a ...


6
David R Elmaleh, Alan J Fischman, Timothy M Shoup: Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid. The General Hospital Corporation, Edwards Wildman Palmer, Peter C Lauro Esq, Mark D Russett Esq, September 18, 2012: US08268291

The present invention relates to novel modified fatty acid analogs, where a positron or gamma-emitting label is placed at a position on a fatty acid backbone and an organic substituent is substituted at the 2,3; 3,4; 4,5; 5,6 and other sequence positions of a fatty acid backbone. These novel fatty a ...


7
Martin Quibell: Inhibitors of cruzipain and other cysteine proteases. Amura Therapeutics, Edwards Angell Palmer & Dodge, Ralph A Loren Esq, Mark D Russett Esq, September 16, 2008: US07425562

Compounds of general formula (I) or general formula (II) wherein R1, P1, P2, Q, Y, (X)o, (W)n, (V)m, Z and U are as defined in the specification, are inhibitors of cruzipain and other cysteine protease inhibitors and are useful as therapeutic agents, for example in Chagas' disease, or for validating ...